Simvastatin composition

A technology of simvastatin and composition, applied in the field of simvastatin composition, can solve problems such as difficulty in controlling simvastatin degradation, error-prone, poor controllability, etc., and achieve low price, avoid harm, and quality controllability strong effect

Inactive Publication Date: 2015-03-04
HUNAN MINGRUI PHARMA
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

CN10330693A proposes to adopt the technique of direct tableting, and CN102106835A uses micronization, powder direct compression technology to prepare simvastatin tablets, but the above two kinds have added antioxidant
Although inclusion technology is beneficial to improve the stability of simvastatin, incomplete inclusion often occurs in actual production. At the same time, the actual production process of inclusion technology is relatively cumbersome and prone to errors
CN102657628A discloses a medicine containing simvastatin and a preparation method thereof, mainly by controlling the drying temperature and time, and adopting a brown composite blister film with excellent barrier properties to pack moisture-proof and light-proof packaging without adding antioxidants and stimulants. Acid agent, but wet granulation is used, it is difficult to control the degradation of simvastatin in the production process, especially the controllability of production is poor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Simvastatin composition
  • Simvastatin composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Example 1 Preparation of Simvastatin Capsules

[0032] Simvastatin 5g

[0033] Microcrystalline Cellulose 130g

[0034] Silica 15g

[0035] Preparation Process:

[0036] Simvastatin and microcrystalline cellulose are mixed uniformly in equal increments, silicon dioxide is added, mixed uniformly, after the content is detected, the capsule shell and capsule filling machine are used for filling, and brown PVC / aluminum foil is used for blister packaging.

Embodiment 2

[0037] Example 2 Preparation of Simvastatin Capsules

[0038] Simvastatin 10g

[0039] Microcrystalline Cellulose 110g

[0040] Silica 30g

[0041] Simvastatin and microcrystalline cellulose are mixed uniformly in equal increments, silicon dioxide is added, mixed uniformly, after the content is detected, the capsule shell and capsule filling machine are used for filling, and brown PVC / aluminum foil is used for blister packaging.

Embodiment 3

[0042] Example 3 Preparation of Simvastatin Capsules

[0043] Simvastatin 15g

[0044] Microcrystalline Cellulose 140g

[0045] Silica 15g

[0046] Simvastatin and microcrystalline cellulose are mixed uniformly in equal increments, silicon dioxide is added, mixed uniformly, after the content is detected, the capsule shell and capsule filling machine are used for filling, and brown PVC / aluminum foil is used for blister packaging.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a simvastatin composition. The composition is formed by uniformly mixing simvastatin, as well as a diluent and a flow agent, which are pharmaceutically acceptable. Simvastatin is mixed with the pharmaceutical diluent in an equivalent incremental manner, and then, the mixture is mixed with the pharmaceutically-acceptable flow agent to obtain simvastatin capsule. According to the invention, on the condition of not adding an antioxygen or an acidifier, the qualified simvastatin capsule is prepared through simple mixing and filling, so that the simvastatin capsule is more stable, controllable and applicable to large-scale production.

Description

technical field [0001] The invention relates to a simvastatin composition, in particular to a simvastatin capsule. Background technique [0002] Simvastatin (simvastatin) is a semi-synthetic HMG-CoA reductase inhibitor based on lovastatin. It was first launched in Switzerland in 1988 and was approved by the US FDA in December 1991. It is a treatment for post-onset hypercholesterolemia. disease drugs. [0003] Simvastatin tablets and capsules currently on the market are mainly used clinically to prevent and treat hyperlipidemia and coronary heart disease, especially the latter, which can reduce the risk of death, reduce coronary heart disease death and non-fatal The risk of myocardial infarction, reduce the risk of stroke and transient cerebral ischemia, reduce the risk of myocardial revascularization surgery (coronary artery bypass grafting and percutaneous balloon coronary angioplasty). [0004] Simvastatin itself is unstable in nature, easy to be oxidized and hydrolyzed,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/366A61K9/48A61K47/38A61K47/26A61K47/04A61K47/02A61K47/12A61P3/06A61P9/10
CPCA61K31/366A61K9/0053A61K9/4833A61K47/02A61K47/12A61K47/26A61K47/38
Inventor 蔡辉李晓斌陈斌
Owner HUNAN MINGRUI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap